Stuart Conway is a Professor of Medicinal Chemistry and the inaugural holder of the Michael and Alice Jung Endowed Chair in Medicinal Chemistry and Drug Discovery at the University of California, Los Angeles. He studied Chemistry with Medicinal Chemistry at the University of Warwick (1994-1997), completing a research project with Prof. Andrew Clark,  before undertaking PhD research at the University of Bristol (1997-2001) with Profs Jeff Watkins FRS and David Jane. Stuart completed post-doctoral studies with Professor Andrew Holmes FRS at the University of Cambridge (2001-2003) and in 2003, he was appointed as a Lecturer in Bioorganic Chemistry at the University of St Andrews. In 2008 was appointed as an Associate Professor at the University of Oxford, and between October 2014 and June 2023 he was a Full Professor at Oxford. He was concurrently the E. P. Abraham Cephalosporin Fellow in Organic Chemistry at St Hugh's College, Oxford. His research focuses on the development of molecular tools to enable the study of biological systems, with a focus on epigenetics, hypoxia, and proximity induction approaches. This work has been recognized by a number of prizes, including the 2012  European Federation for Medicinal Chemistry Prize for a Young Medicinal Chemist, the 2024 European Federation for Medicinal Chemistry UCB-Ehrlich Award, and the 2024 ACS Division of Medicinal Chemistry Robert M. Scarborough Award, awarded for excellence in medicinal chemistry.

Stuart has played an active role in the chemical biology, organic, and medicinal chemistry communities, serving as the President of the RSC Organic Division (2019-2022), an Associate Editor for the Journal of Medicinal Chemistry (2016-2024) and ACS Bio & Med Chem Au (2021-2024), and a member of the EFMC Advisory Board (2016-2018). He is currently the Treasurer of the ACS Division of Medicinal Chemistry.